IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Gaudium IVF and Women Health IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in New Delhi and caters to Healthcare sector. Sarthi Capital Advisors is the merchant banker of Gaudium IVF and Women Health IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 20th January 2025.
Gaudium IVF and Women Health IPO posted revenues of ₹ 63.38 crores and PAT of ₹ 16.28 crores in FY25 on annualised basis.
Revenue:
₹ 63.38 Cr.
EBITDA Margin:
39.73
% 
Net Worth: ₹ 41.55 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Financial results of Gaudium IVF and Women Health IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-24 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 72.27 | 57.29 | 36.63 | 17.77 | |
| Net Worth | 41.55 | 33.27 | 22.73 | 22.73 | |
| Total Debt | 19.48 | 15.73 | 9.78 | 5.95 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
31.69
63.38 |
53.48 | 44.24 | 36.52 | |
EBITDA
EBITDA on annualised basis |
12.59
25.18 |
25.82 | 20.08 | 13.42 | |
PAT
PAT on annualised basis |
8.14
16.28 |
16.60 | 13.52 | 8.83 | |
Gaudium IVF and Women Health IPO PAT Margin is 25.69 % , ROCE (Return on Capital Employed) is 18.15 % as per latest financial. The below table shows Gaudium IVF and Women Health IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-24 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| EBITDA Margin (%) | 39.73 | 48.28 | 45.39 | 36.75 |
| PAT Margin (%) | 25.69 | 31.04 | 30.56 | 24.18 |
| EPS (₹) | 1.33 | 2.70 | 2.20 | 1.44 |
| ROE (%) | 19.59 | 49.89 | 59.48 | 38.85 |
| ROCE (%) | 18.15 | 46.27 | 54.40 | 81.65 |
| ROA (%) | 11.26 | 28.98 | 36.91 | 49.69 |
| Debt to Equity | 0.47 | 0.47 | 0.43 | 0.26 |
The market Capitalisation of Gaudium IVF and Women Health IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Gaudium IVF and Women Health IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Gaudium IVF and Women Health IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Gaudium IVF and Women Health IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Gaudium IVF and Women Health IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Gaudium IVF and Women Health IPO reported revenue of ₹ 63.38 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Gaudium IVF and Women Health IPO provide insights into sales growth, market demand, and business scalability.
Gaudium IVF and Women Health recorded an EBITDA of ₹ 25.18 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Gaudium IVF and Women Health Profit After Tax (PAT) is ₹ 16.28 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 63.38 Cr.
EBITDA Margin:
39.73
%
Net Worth: ₹ 41.55 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Gaudium IVF and Women Health operates in Healthcare and . The Issue is listed on BSE,NSE in May, 2025. Gaudium IVF and Women Health IPO size was with Issue price of .
Merchant Banker(s) of Gaudium IVF and Women Health IPO: Sarthi Capital Advisors Private Limited
Gaudium IVF and Women Health IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Gaudium IVF and Women Health IPO listed at a listing price of against the offer price of .
The current market price of Gaudium IVF and Women Health is .
Why Us?
